Jan 21, 2026
319:303
For every 303 shares held, investors received 319. The price per share adjusted from $42.95 to $40.80.
The split itself did not change the total investment value.
Great Novel Therapeutics Biotech & Medicals Corp. (TPEX:7427) operates in the Miscellaneous commercial services industry.
Great Novel Therapeutics Biotech & Medicals Corp. company overviewGreat Novel Therapeutics Biotech & Medicals Corp.'s most recent stock split was on January 21, 2026. It was a 319-for-303 forward split, so shareholders received 319 shares for every 303 they held.
Great Novel Therapeutics Biotech & Medicals Corp. (TPEX:7427) has split its stock 4 times: a 926-for-899 split on August 12, 2022, a 581-for-528 split on January 31, 2023, a 869-for-835 split on April 25, 2024, and a 319-for-303 split on January 21, 2026.
Great Novel Therapeutics Biotech & Medicals Corp. has split its stock 4 times. This history records 4 forward splits between August 12, 2022 and January 21, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Great Novel Therapeutics Biotech & Medicals Corp.'s 319-for-303 split on January 21, 2026, every 303 shares became 319 shares.
Great Novel Therapeutics Biotech & Medicals Corp. has not announced a new split in our records. Its most recent split was on January 21, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:7427 split will appear on this page.
Already premium?